Search
for
Sort by
Research 571–600 of 1000+
- Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Restoration of Spermatogenesis and Male Fertility Using an Androgen Receptor Transgene
- Androgens in cervical cancer: Their role in epidemiology and biology
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Disruptors of Androgen Action and Synthesis
- Structural perspectives on the androgen receptor, the elusive shape-shifter
- Androgen-induced norepinephrine release in male accessory sex organ smooth muscle growth and differentiation
- Androgens in postmenopausal women
- Androgen Signaling in Sertoli Cells
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Pharmacology of anabolic steroids
- Molecular mechanisms of androgenetic alopecia
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Intracrine androgen biosynthesis, metabolism and action revisited
- Adult polycystic ovary syndrome begins in childhood
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Nonclassic adrenal hyperplasia
- Endogenous retinoids in the hair follicle and sebaceous gland
- Evidence-based approach to cutaneous hyperandrogenism in women
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Circulating androgen regulation by androgen-catabolizing gut bacteria in male mouse gut
- Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens